Aprea Therapeutics Inc
General ticker "APRE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.3M
Aprea Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.2%.
Estimated limits based on current volatility of 5.1%: low 3.08$, high 3.42$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.03$, 8.34$]
- 2024-12-30 to 2025-12-30 estimated range: [2.16$, 6.08$]
Financial Metrics affecting the APRE estimates:
- Negative: Non-GAAP EPS, $ of -3.99 <= 0.10
- Negative: Operating profit margin, % of -96.37 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -47.07 <= 2.35
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
Short-term APRE quotes
Long-term APRE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.64MM | $1.46MM | $0.58MM |
| Operating Expenses | $37.45MM | $113.39MM | $16.06MM |
| Operating Income | $-36.81MM | $-111.93MM | $-15.47MM |
| Non-Operating Income | $0.00MM | $0.00MM | $1.19MM |
| Interest Expense | $0.00MM | $0.45MM | $0.00MM |
| R&D Expense | $23.90MM | $16.40MM | $7.63MM |
| Income(Loss) | $-36.81MM | $-111.93MM | $-14.29MM |
| Profit(Loss) | $-36.81MM | $-111.93MM | $-14.29MM |
| Stockholders Equity | $49.51MM | $25.64MM | $18.26MM |
| Assets | $56.82MM | $30.16MM | $22.65MM |
| Operating Cash Flow | $-37.69MM | $-25.01MM | $-12.18MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.09MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-0.09MM |
| Financing Cash Flow | $1.75MM | $0.68MM | $5.14MM |
| Earnings Per Share* | $-34.33 | $-2,714.18 | $-3.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.